A role for the complement alternative pathway in the pathology of multiple sclerosis grey matter lesions

被引：0
|
作者：
Watkins, Lewis M. [1 ]
Loveless, Samantha [2 ]
Neal, James [3 ]
Rees, Mark I. [1 ]
Robertson, Neil [2 ]
Reynolds, Richard [4 ]
Morgan, B. Paul [3 ]
Howell, Owain W. [1 ]
机构：
[1] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales
[2] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales
[3] Cardiff Univ, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales
[4] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.335
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
324
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [21] The role of lymphotoxin-alpha and CXCL13 in grey matter pathology in multiple sclerosis
    Browne, E. J.
    Schalks, R. M.
    Reynolds, R.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 58 - 59
  • [22] Grey matter atrophy in the visual pathway of multiple sclerosis patients
    Sepulcre, J.
    Gallego, J.
    Goni, J.
    Velez de Mendizabal, N.
    Villoslada, P.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S176 - S176
  • [23] Grey and white matter pathology in multiple sclerosis: separate effects on cognition?
    Eijlers, A. J.
    Meijer, K. A.
    van Geest, Q.
    Geurts, J. J.
    Schoonheim, M. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 82 - 82
  • [24] The relationship between grey matter and white matter pathology weakens in progressive multiple sclerosis
    Sethi, V.
    Yousry, T.
    Muhlert, N.
    Ron, M.
    Golay, X.
    Wheeler-Kingshott, C.
    Miller, D.
    Chard, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 420 - 421
  • [25] Pathological differences between white and grey matter multiple sclerosis lesions
    Prins, Marloes
    Schul, Emma
    Geurts, Jeroen
    van der Valk, Paul
    Drukarch, Benjamin
    van Dam, Anne-Marie
    [J]. NEUROIMMUNOMODULATION IN HEALTH AND DISEASE, 2015, 1351 : 99 - 113
  • [26] Cortical atrophy in multiple sclerosis may start at puberty grey matter pathology
    Stawiarz, L.
    Granberg, T.
    Manouchehrinia, A.
    Hagel, E.
    Hillert, J.
    Forsberg, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 11 - 12
  • [27] Grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space
    Howell, O.
    Schulz-Trieglaff, E. K.
    Carassiti, D.
    Gentleman, G. M.
    Nicholas, R.
    Roncaroli, F.
    Reynolds, R.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 : 19 - 20
  • [28] Efficacy of dimethyl-fumarate in preventing grey matter pathology in multiple sclerosis
    Zuco, C.
    Marastoni, D.
    Pizzini, F. B.
    Pitteri, M.
    Pisani, A. I.
    Crescenzo, F.
    Castellaro, M.
    Guandalini, M.
    Ziccardi, S.
    Montemezzi, S.
    Scalfari, A.
    Monaco, S.
    Magliozzi, R.
    Calabrese, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 278 - 279
  • [29] Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study
    Codella, M
    Rocca, MA
    Colombo, B
    Martinelli-Boneschi, F
    Comi, G
    Filippi, M
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 194 (01) : 71 - 74
  • [30] Assessment of Individual Grey Matter Pathology Is Clinically Relevant in Early Multiple Sclerosis
    Pelletier, Jean
    Crespy, Lydie
    Zaaraoui, Wafaa
    Lemaire, Mathias
    Rico, Audrey
    Faivre, Anthony
    Reuter, Francoise
    Malikova, Irina
    Cozzone, Patrick
    Ranjeva, Jean-Philippe
    Audoin, Bertrand
    [J]. NEUROLOGY, 2011, 76 (09) : A326 - A326
12345